drugset / Trial / NCT01593072

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

NCT01593072 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of healthy male and female subjects with intravenous (IV) infusions of AVI 7537 compared to matched placebo in and to evaluate the pharmacokinetics (PK).

Timeline

Start
2012-08
Primary completion
2013-01
Completion
2013-01

Outcome

Outcome not reported

Stopped (Business): “Terminated for convenience of the Government due to funding constraits”

Drugs

EvaluationDrugModalityDoseRoute
Comparator AVI-7537 Unknown 4.5 mg/kg Intravenous
Comparator AVI-7537 Unknown 9 mg/kg Intravenous
Comparator AVI-7537 Unknown 15 mg/kg Intravenous
Comparator AVI-7537 Unknown 30 mg/kg Intravenous